Onc Flashcards

(31 cards)

1
Q

What’s the medication indicated for non-metastatic castrate resistant prostate cancer

A

Androgen receptor blocker

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What’s bone-seeking isotope?

A

It’s a treatment for metastatic prostate cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What treatment does a patient with small cell lung cancer with complete response after Qt and Rt?

A

Prophylactic cranial irradiation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Whats the treatment for non–small cell lung cancer who are not candidates for surgery?

A

For patients with non–small cell lung cancer who are not candidates for surgery, stereotactic radiation therapy can be used to treat stage I cancers.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What’s the indication of HT screening of pts on trastuzumab?

A

TTE for those at high risk
2 of: DM, HTN, DLP, smoking, obesity
> 60 yo on dx
concurrent use of anthracicline

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Treatment of cancer of unknown primary

A

If advanced, should start chemo: unless finding the primary source would change management

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Metastatic cancer of unknown primary in women and abd carcinimatosis: how to approach

A

Women who have adenocarcinoma with abdominal carcinomatosis and ascites should be presumptively treated for ovarian cancer.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Patients with bulky or locally advanced stage III cervical cancer

A

Cisplatin and radiation therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Pt with previous breast cancer history and new axillary lymph node + new pulmonary nodules: what to do

A

Biopsy the PULMONARY nodule: bx whatever upstages the pt

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Women with advanced ovarian cancer and BRCA mutations who achieve some response to platinum-based chemotherapy should receive

A

maintenance therapy with a poly (ADP-ribose) polymerase inhibitor.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Patients who have good performance with metastatic non–small cell lung cancer with negative PD-L1 treatment

A

Pembrolizumab + chemotherapy (regardless of PD-1 status)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Treatment of depression in patients taking tamoxifen

A

Antidepressants with strong CYP2D6 inhibition, such as bupropion or fluoxetine, may decrease tamoxifen activation and should be avoided. Use venlafaxine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Well-differentiated, low-grade, metastatic gastrointestinal neuroendocrine tumors, treatment?

A

indolent and asymptomatic and do not require immediate treatment: expectant observation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Genetic testing for BRCA gene mutation should be done in all men with prostate cancer and…

A

high-risk disease, including patients with a Gleason score >7, positive lymph nodes, or metastatic disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

For women survivors of Hodgkin lymphoma who received chest irradiation between ages 10 and 30 years, breast CA screening?

A

Annual breast cancer screening with MRI is recommended to begin 8 to 10 years post-therapy or at age 25 years, whichever comes last, with mammography in addition to MRI beginning at age 30 years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Treatment of extra-gastric MALT

A

The treatment of mucosa-associated lymphoma tissue (MALT) lymphomas other than gastric MALT lymphoma may include irradiation for localized disease or rituximab when systemic therapy is required.

17
Q

For patients who have breast cancer with bone metastases, additional treatment other than chemo

A

bone-modifying agents such as zoledronic acid or denosumab are recommended to prevent bone-related events

18
Q

Texturized breast implant with periprosthetic fluid collection

A

Anaplastic large cell lymphoma

19
Q

In men undergoing active surveillance for prostate cancer, what change in PSA warrants re-biopsy?

A

Doubling in less than 3 years

20
Q

Indication of androgen receptor blocker in patients with prostate cancer

A

castrate-resistant prostate cancer with rapidly rising prostate-specific antigen levels

21
Q

For patients with hormone receptor–positive, human epidermal growth factor 2–negative breast cancers with no positive axillary nodes, treatment?

A

Determined by multigene assays

22
Q

For metastatic non–small cell lung cancer with an ALK translocation, treatment?

23
Q

What to test with the gastroesophageal tumors that determines therapy?

A

Testing HER2 (human epidermal growth factor receptor) overexpression: to add trastuzumab

25
Treatment of non–small cell lung cancer who are not candidates for surgery stage I
Stereotactic radiation
26
Secondary causes of polycythemia other than hypoxia
Renal cell cancer: high erythropoietin and normal O2 and hematuria
27
Patients with prostate-specific antigen (PSA)–only recurrence of prostate cancer and a slow PSA doubling time
Active survaillance For men with a rapid doubling time, defined as 10 months or less, treatment is generally recommended
28
Pt with ductal carcinoma in situ s/p bil mastectomy and postive lymph nodes
No adjuvant therapy: not indicated in carcinoma in situ after total mastectomy even with positive lymph node
29
30
Prophylactic cranial irradiation reduces the incidence of brain metastases in patients with
limited or extensive-stage small cell lung cancer who have responded to their initial therapy.
31
Treatment for high grade GIST
Imatinib for 3 years